- Investing Ideas
- /
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
10
Companies which are more than 50% undervalued based on analyst price target.
10 companies
Gerresheimer
Market Cap: €1.8b
Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€50.80
7D
-4.2%
1Y
-49.2%
Evotec
Market Cap: €1.1b
Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
EVT
€5.82
7D
9.4%
1Y
-55.9%
Formycon
Market Cap: €416.7m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€23.35
7D
14.5%
1Y
-41.9%
PharmaSGP Holding
Market Cap: €287.8m
Manufactures and sells over-the-counter drugs and other healthcare products in Germany.
PSG
€24.20
7D
-1.6%
1Y
12.0%
Heidelberg Pharma
Market Cap: €126.8m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.
HPHA
€2.60
7D
-1.1%
1Y
-12.2%
MPH Health Care
Market Cap: €99.8m
An investment company, engages in the healthcare business in Germany.
93M1
€22.70
7D
3.7%
1Y
13.5%
Cantourage Group
Market Cap: €57.4m
Operates as a medical cannabis company in Europe.
HIGH
€4.55
7D
4.8%
1Y
-42.4%
Vidac Pharma Holding
Market Cap: €31.0m
An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.
T9G
€0.60
7D
0%
1Y
172.7%
SynBiotic
Market Cap: €21.2m
Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.
SBX
€3.12
7D
8.9%
1Y
-68.9%
Medigene
Market Cap: €2.8m
A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.
MDG1
€0.17
7D
-15.2%
1Y
-95.3%